Lowey Dannenberg, P.C. is Investigating Integra LifeSciences Holdings Corporation (NASDAQ: IART) for Potential Breaches of Fiduciary Duty by Its Board of Directors

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Integra LifeSciences Holdings Corporation (NASDAQ: IART) (“Integra”).

If you are a long-term shareholder of Integra, and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact Andrea Farah at afarah@lowey.com or (914) 733-7256 or Vincent Cappucci at vcappucci@lowey.com or (914) 733-7278.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  investigations@lowey.com

SOURCE: Lowey Dannenberg


Primary Logo

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.35
-1.31 (-0.56%)
AAPL  332.29
+10.63 (3.30%)
AMD  527.05
-12.64 (-2.34%)
BAC  61.91
+0.62 (1.02%)
GOOG  320.00
+1.66 (0.52%)
META  602.11
-3.99 (-0.66%)
MSFT  384.10
+2.52 (0.66%)
NVDA  207.95
-0.81 (-0.39%)
ORCL  116.77
-3.27 (-2.72%)
TSLA  307.50
-12.19 (-3.81%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.